Methylene Blue
Methylthioninium Chloride · MB
A 150-year-old dye that doubles as a mitochondrial enhancer and neuroprotectant. Yes, it turns things blue.
What is Methylene Blue?
Methylene blue might be the most surprising compound in biohacking. It is a synthetic dye first created in 1876, originally used for staining microscope slides. Over the past century, it has been repurposed multiple times: as an antimalarial, a treatment for methemoglobinemia (it is FDA-approved for this), a urinary antiseptic, and now — as a mitochondrial enhancer and nootropic.
The biohacking interest centres on its unique ability to act as an alternative electron carrier in the mitochondrial electron transport chain. When mitochondria are dysfunctional (which happens increasingly with age, stress, and disease), methylene blue can bypass damaged complexes and keep ATP production flowing. Think of it as a bypass road when the motorway is blocked.
At low doses, users report improved mental clarity, better energy, and enhanced mood. At high doses, it is a legitimate medical treatment. The dose-response is biphasic — low doses are stimulatory (hormetic) while high doses can be inhibitory. Getting the dose right matters more with methylene blue than almost any other compound.
How Does It Work?
Methylene blue cycles between oxidised (blue) and reduced (clear) forms, allowing it to accept and donate electrons directly within the mitochondrial electron transport chain. When Complex I or III are impaired, methylene blue can shuttle electrons directly to Complex IV (cytochrome c oxidase), maintaining ATP production.
Additionally, it inhibits monoamine oxidase (MAO) — which increases serotonin, norepinephrine, and dopamine availability (explaining mood and cognitive effects). It also inhibits nitric oxide synthase, reduces tau protein aggregation (relevant to Alzheimer's), and has antioxidant properties at low concentrations.
What Does The Research Say?
Strong clinical evidence from human trials.
FDA-approved for methemoglobinemia. Extensive research for Alzheimer's disease: Phase III trials (TauRx Therapeutics) showed some benefit in treatment-naive patients. Studies show improved mitochondrial function, reduced oxidative stress, and neuroprotection in multiple animal models.
Human cognitive studies: A University of Texas study showed methylene blue improved memory retention and fMRI brain activity in healthy adults. Animal longevity studies show modest lifespan extension. The evidence base is surprisingly robust for something that started life as a fabric dye.
Reported Dosages
These are dosages reported in research literature and community reports. They are NOT medical recommendations. Always consult a healthcare professional.
Nootropic/biohacking: 0.5-4mg/kg orally (typically 15-60mg for most people).
USP pharmaceutical grade essential (avoid industrial/lab grade).
FDA-approved dose (methemoglobinemia): 1-2mg/kg IV.
Start very low (0.5mg/kg) and titrate up.
Taken in morning (can interfere with sleep due to MAO inhibition).
IMPORTANT: Contraindicated with SSRIs (serotonin syndrome risk).
Side Effects & Risks
Blue/green discolouration of urine and potentially tongue/lips (harmless but alarming). GI upset at higher doses. Headache. DANGEROUS interaction with SSRIs and other serotonergic drugs (risk of serotonin syndrome). Contraindicated in G6PD deficiency. Photosensitivity.
Legal Status by Country
Legal to purchase. Prescription medication for specific indications. USP grade available.
FDA-approved for methemoglobinemia. USP grade available without prescription for other uses.
Prescription medication for approved indications. Available as supplement in some countries.
Prescription medication. TGA Schedule 4.
Important Disclaimer
This profile is for educational and research purposes only. It does not constitute medical advice. Methylene Blue may be regulated or illegal in your jurisdiction. Do not use any compound without consulting a qualified healthcare professional. StackPedia does not sell, supply, or promote the use of any controlled substance.